A program to explore and commercialize digital therapeutics, digital devices, novel diagnostic technologies, implantable medical devices and other businesses as standalone revenue-generating operations independent of prescription pharmaceuticals. It also includes the development and operation of a distribution platform, supporting diversification into the medical solutions business.